Contaminating reactivity of a monoclonal CCAAT/Enhancer Binding Protein β antibody in differentiating myoblasts.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
31 Oct 2019
Historique:
received: 18 07 2019
accepted: 18 10 2019
entrez: 2 11 2019
pubmed: 2 11 2019
medline: 31 3 2020
Statut: epublish

Résumé

CCAAT/Enhancer Binding proteins (C/EBPs) are transcription factors involved in the regulation of a variety of cellular processes. We used the Abcam Recombinant Anti-C/EBP beta antibody (E299) to detect C/EBPβ expression during myogenesis. Though the antibody is monoclonal, and the immunogen used is highly specific to C/EBPβ, we identified an intense band at 23 kDa on western blot that did not correspond to any of the known isoforms of C/EBPβ, or family members predicted to cross-react. Absent in myoblast cells overexpressing C/EBPβ, the band was present when C/EBPβ was knocked down, confirming specificity for a protein other than C/EBPβ. The objective of this work was to identify the contaminating reactivity. We performed immunoprecipitation followed by mass spectrometry to identified myosin light chain 4 (MYL4) as the unknown band, suggesting that the Abcam monoclonal antibody directed against C/EBPβ is not pure, but contains a contaminating antibody against MYL4. Caution should be used when working in cells lines that express MYL4 to not confound the detection of MYL4 with that of C/EBPβ isoforms.

Identifiants

pubmed: 31672165
doi: 10.1186/s13104-019-4749-3
pii: 10.1186/s13104-019-4749-3
pmc: PMC6824081
doi:

Substances chimiques

Antibodies, Monoclonal 0
CCAAT-Enhancer-Binding Protein-beta 0
CEBPB protein, human 0
MYL4 protein, human 0
Myosin Light Chains 0
Protein Isoforms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717

Subventions

Organisme : CIHR
ID : 148613
Pays : Canada

Références

Nature. 1975 Aug 7;256(5517):495-7
pubmed: 1172191
Anat Rec. 1975 Jun;182(2):215-35
pubmed: 168794
Stem Cells. 2012 Dec;30(12):2619-30
pubmed: 23034923
J Biophys Biochem Cytol. 1961 Feb;9:493-5
pubmed: 13768451
Mol Cell. 2012 Aug 10;47(3):457-68
pubmed: 22771117
MAbs. 2018 May/Jun;10(4):539-546
pubmed: 29485921
J Biol Chem. 2015 Apr 17;290(16):10200-7
pubmed: 25720496
Cell. 1991 Nov 1;67(3):569-79
pubmed: 1934061
Sci Rep. 2018 Nov 9;8(1):16613
pubmed: 30413755
Genes Dev. 1991 Sep;5(9):1538-52
pubmed: 1840554
Cytokine. 2011 Apr;54(1):6-19
pubmed: 21257317
Nat Protoc. 2006;1(6):2856-60
pubmed: 17406544
Genes Dev. 2000 Aug 1;14(15):1920-32
pubmed: 10921906

Auteurs

Hamood AlSudais (H)

Graduate Program in Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Rm 3106, K1H 8M5, Ottawa, ON, Canada.

Nadine Wiper-Bergeron (N)

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Rm 2539, K1H 8M5, Ottawa, ON, Canada. Nadine.WiperBergeron@uottawa.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH